Navigation Links
Kewaunee Scientific Reports Results

Net Earnings for Year Increase 104%, Sales Increase 9.9%

STATESVILLE, N.C., June 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its fiscal year and fourth quarter ended April 30, 2008.

Net earnings for the year increased 104% to $3,134,000, or $1.23 per diluted share, up from net earnings of $1,540,000, or $0.62 per diluted share, in the prior year. Earnings benefited from a strong performance from the Company's domestic operations, improved profit margins, and continued growth of its international operations.

Sales for the year increased 9.9% to $89,510,000, up from sales of $81,441,000 in the prior year. Incoming orders were strong throughout the year, both domestic and international. The order backlog was a record year-end level of $58.7 million at April 30, 2008, up from $51.1 million at April 30, 2007. Sales from domestic operations increased to $73,768,000, up 10.8% from the prior year. Sales from international operations increased to $15,742,000, up 6.0% from the prior year.

"We made progress in a number of important areas in fiscal year 2008," said William A. Shumaker, President and Chief Executive Officer. "We are particularly pleased with the performance of our domestic operations, which were successful in increasing sales over all major product lines, building up our order backlog to record levels, and reducing manufacturing costs. Our international operations continued to execute well, with continued growth in sales, earnings, and order backlog during the year. In addition to operational accomplishments, our Statesville operations successfully moved to a new comprehensive ERP business management system late in the fourth quarter, and we successfully completed our project to become Sarbanes-Oxley Section 404 compliant.

"Our continued successes in fiscal year 2008 have made us a much stronger Company and keeps us on a solid track for long-term success and profitability," continued Mr. Shumaker. "Looking toward fiscal year 2009, we begin the year with a strong order backlog, good operating momentum, and healthy marketplaces for our products, both domestically and internationally. Like many businesses, we are challenged these days with extraordinary escalations in prices of raw materials, particularly steel and epoxy resin, energy, and transportation costs. We are aggressively pursuing strategies to minimize these increases."

The Company's financial condition further strengthened during the year. Working capital increased to $15.9 million at April 30, 2008, up from $12.3 million at the end of the prior year. Cash on hand at the end of the year increased to $4.3 million, up from $2.6 million at the end of the prior year. Bank borrowings and capital lease obligations were $5.0 million at year-end, as compared to $4.3 million at the end of the prior year, and the debt-to-equity ratio was .19-to-1 at year-end, as compared to .18-to-1 at the end of the prior year.

Net earnings for the fourth quarter were $446,000, or $.17 per diluted share, as compared to net earnings of $517,000, or $.21 per diluted share, in the prior year. Sales for the fourth quarter were $22,116,000, down slightly from sales of $22,721,000 in the same quarter of the prior year. Sales from domestic operations for the quarter were flat with the same quarter of the prior year, while sales from international operations declined slightly. Shipments and earnings were unfavorably impacted by inefficiencies and expenses associated with the Company's conversion during the quarter to a new comprehensive ERP system which incorporated all of the Company's business management systems.

As recently announced, the Company increased its quarterly cash dividend to eight cents per outstanding share, up from seven cents per share declared in the previous quarter.

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters and domestic manufacturing facilities are located in Statesville, North Carolina. The Company also has subsidiaries in Singapore and Bangalore, India that serve the Asian and Middle East markets. Kewaunee Scientific's website is located at .

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.

Consolidated Statements of Operations

(in thousands, except per share data)

Three Months Ended Year Ended

April 30 April 30

2008 2007 2008 2007


Net sales $22,116 $22,721 $89,510 $81,441

Cost of products sold 17,579 18,467 70,338 66,355

Gross profit 4,537 4,254 19,172 15,086

Operating expenses 3,748 3,363 13,559 11,728

Operating earnings 789 891 5,613 3,358

Other income 49 20 47 53

Interest expense 8 (146) (294) (670)

Earnings before

income taxes 846 765 5,366 2,741

Income tax expense 342 289 1,733 902

Earnings before minority

interests 504 476 3,633 1,839

Minority interests in

subsidiaries (58) 41 (499) (299)

Net earnings $446 $517 $3,134 $1,540

Net earnings per share

Basic $0.17 $0.21 $1.24 $0.62

Diluted $0.17 $0.21 $1.23 $0.62

Weighted average number

of common shares


(in thousands)

Basic 2,551 2,494 2,530 2,493

Diluted 2,577 2,502 2,557 2,495

Condensed Consolidated Balance Sheets

(in thousands)

April 30 April 30

Assets 2008 2007

Cash and cash equivalents $3,784 $2,231

Restricted cash 480 372

Receivables, less allowances 20,561 19,061

Inventories 6,984 5,869

Prepaid expenses and other current assets 1,847 981

Total current assets 33,656 28,514

Net property, plant and equipment 11,825 11,255

Other assets 5,599 5,471

Total Assets $51,080 $45,240

Liabilities and Stockholders' Equity

Short-term borrowings $4,551 $3,489

Current obligations under capital leases 323 360

Accounts payable 8,929 8,437

Other current liabilities 3,933 3,897

Total current liabilities 17,736 16,183

Other non-current liabilities 6,397 5,009

Total stockholders' equity 26,947 24,048

Total Liabilities and Stockholders' Equity $51,080 $45,240

Contact: D. Michael Parker


SOURCE Kewaunee Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kewaunee Scientific Corporation Increases Quarterly Dividend
2. Nerites Technology Wins Scientific Accolades
3. American Scientific Resources, Inc. Discloses Reviewed Financials
4. Boston Scientific Welcomes Progress on Pain Care Legislation
5. A Simple Weight Loss Diet: Scientific, Safe and Basically Free
6. Gerber Scientific to Hold Fiscal Year 2008 Fourth Quarter and Full Year Conference Call
7. Paramount Farms Establishes Scientific Advisory Board to Advance Understanding of the Health Benefits of Pistachios
8. ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations
9. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
10. Milestone Scientific Expands U.S. and Canadian Distribution Network With Addition of Patterson Dental Supply
11. The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is ... 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an ... every day excited to rebuild lives and it’s an honor to have served all ...
(Date:11/26/2015)... Karnataka (PRWEB) , ... November ... ... innovative online platform for mental health and wellness consultation, has collaborated with ... to holistically address their reader’s queries on topics on mental and emotional ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part ... For Empowerment ™ attracts volunteers together who want to combine talents and resources ... key stakeholders in the process. The non-profit launched its first major fundraiser on ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... been recognized once again for its stellar workplace culture with the company’s Cincinnati ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati Business ...
(Date:11/25/2015)... ... , ... Ministers, senior government and UN agencies, representatives from ... Excellence, and public R&D institutions, civil societies and other partners gathered today at ... Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day meeting ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Therapeutic Drug Monitoring (TDM) ... Competitive Intelligence, Emerging Opportunities"  report to ... ) has announced the addition of ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
Breaking Medicine Technology: